Evotec SE (EVOTF) Other Working Capital Changes (2021 - 2026)
Evotec SE's (EVOTF) quarterly Other Working Capital Changes came in at $83696.6 in Q1 2026, up 339.66% year-on-year from $19036.8 in Q1 2025, and up 174.42% quarter-over-quarter from -$112459.6 in Q3 2025.
Evotec SE (EVOTF) Other Working Capital Changes (2021 - 2026) Analysis & Trends
Evotec SE has disclosed Other Working Capital Changes across 6 years of filings, most recently posting $83696.6 for Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Evotec SE | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 83,696.61 |
| Mar 31, 2026 | 83,696.61 |
| Sep 30, 2025 | -112,459.59 |
| Sep 30, 2025 | -112,459.59 |
| Jun 30, 2025 | 70,544.86 |
| Jun 30, 2025 | 70,544.86 |
| Mar 31, 2025 | -34,923.62 |
| Mar 31, 2025 | -34,923.62 |
| Sep 30, 2024 | 55,469.97 |
| Sep 30, 2024 | 55,469.97 |
| Jun 30, 2024 | -15,226.11 |
| Jun 30, 2024 | -15,226.11 |
| Mar 31, 2024 | -65,314.24 |
| Mar 31, 2024 | -65,314.24 |
| Sep 30, 2023 | 13,026.07 |
| Sep 30, 2023 | 13,026.07 |
| Jun 30, 2023 | -77,053.38 |
| Jun 30, 2023 | -77,053.38 |
| Mar 31, 2023 | 36,836.02 |
| Mar 31, 2023 | 36,836.02 |